Our mission is to empower clinicians and health care actors with access to real time patient data there by allowing them to make prompt and informed decisions. This results in a better outcome for the patient. Digital technology and innovations in healthcare are empowering patients and transforming the medical industry.
Post-surgery care is crucial, but clinicians often lack real-time insights into their patients' recovery until the next scheduled appointment which can lead to delayed interventions when timely care is most needed.
The current approach is reactive, with clinicians unable to intervene proactively when complications arise. Globally, 20% of patients are readmitted after surgery, highlighting the need for more immediate insights into recovery.
Adherence to post-treatment exercises and/or medication is poor. Studies show that 25-30% of patients do not follow rehabilitation exercises, and 40% fail to adhere to their medication regime, affecting recovery.
The global mHealth market size was valued at USD 56.8 bBillion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 10.8% from 2023 to 2030.
Growing adoption of mHealth technology and platforms by physicians and patients alike are anticipated to propel market growth coupled with advancements in technology capabilities and AI.
Medytrak’s aim is to enter the market now and to be well positioned as the mHealth remote monitor of choice for HCPs.
The TAM consists of Consultants, Dentists, Clinical Trials, GPs, nutritionists and any practice delivering treatment to patients/clients, 1.2 million surgeries in Ireland per annum. International Market (10M UK, 60M EU, 50M USA).
"At MedyTrak, we're excited to be featured in HIHI's latest clinical evaluation study this July. Our cutting-edge mhealth remote symptom tracker is designed to bridge the gap between patient and healthcare provider. By enabling real-time data collection and seamless sharing of patient information, even through an NFC-enabled card for internet access, we empower practitioners to make more informed decisions during in-clinic consultations